Daily Stock Analysis, VEA, Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California., priceseries

Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.. Daily Stock Analysis
Stock Information
Open
45.23
Close
44.13
High
45.24
Low
43.94
Previous Close
45.47
Daily Price Gain
-1.34
YTD High
51.92
YTD High Date
Jan 13, 2022
YTD Low
43.94
YTD Low Date
Mar 7, 2022
YTD Price Change
-7.24
YTD Gain
-14.09%
52 Week High
52.47
52 Week High Date
Sep 3, 2021
52 Week Low
43.94
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-2.63
52 Week Gain
-5.63%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Nov 3. 2020
39.31
Nov 30. 2020
43.31
18 Trading Days
10.17%
Link
Company Information
Stock Symbol
VEA
Exchange
NASDAQ
Company URL
http://www.veracyte.com
Company Phone
(650) 243-6300
CEO
Bonnie H. Anderson
Headquarters
California
Business Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA 94080
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001384101
About

Description

Veracyte, Inc. operates as a molecular diagnostics company in the United States. The company uses genomic technology to resolve diagnostic ambiguity. It offers Afirma Thyroid FNA Analysis solution for use in thyroid cancer diagnosis; cytopathology testing services; and the Afirma Malignancy Classifiers to manage thyroid nodule patients. The company's products also include Percepta Bronchial Genomic Classifier solution for use in lung cancer screening and diagnosis; and Envisia Genomic Classifier solution for idiopathic pulmonary fibrosis. It sells its products through its product specialists, institutional channel managers, account managers, and clinical science specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.